Delving into the Latest Updates on Phacolysin with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

Sodium 5,12-dihydroazapentacene disulfonate, Sodium dihydroazapentacene polysulfonate

Target-

Mechanism-

Therapeutic Areas

Eye Diseases

Active Indication

Cataract

Inactive Indication-

Originator Organization-

Active Organization-

Inactive Organization-

Drug Highest PhaseApproved

First Approval Date-

Regulation-

Login to view timeline

Structure

Molecular FormulaC18H12N4Na2O6S2

InChIKeyVEWTWCXUHBUOJF-UHFFFAOYSA-N

CAS Registry3863-80-7

The interaction between Phacolysin (PCL) and bovine serum albumin (BSA) under imitated physiological conditions was investigated by spectroscopic (fluorescence, UV-Vis absorption and Circular dichroism) techniques. The experiments were conducted at different temperatures (294K, 302K, 306K and 310K) and the results showed that the PCL caused the fluorescence quenching of BSA through a static quenching procedure. The binding constant (Ka), binding sites (n) were obtained. The corresponding thermodynamic parameters (ΔH, ΔS and ΔG) of the interaction system were calculated at different temperatures. The results revealed that the binding process was spontaneous and the acting force between PCL and BSA were mainly hydrogen bonding and van der Waals forces. According to Förster non-radiation energy transfer theory, the binding distance between PCL and BSA was calculated to be 2.41nm. What is more, both synchronous fluorescence and Circular dichroism spectra confirmed the interaction, which indicated the conformational changes of BSA.

100 Deals associated with Phacolysin

Login to view more data